Court denies Lilly’s application to block GSK SPC

23-07-2014

Court denies Lilly’s application to block GSK SPC

Laurin Rinder / Shutterstock.com

The English High Court has dismissed an application by Eli Lilly to stop Human Genome Sciences (HGS) from receiving a supplementary protection certificate (SPC) based on a marketing authorisation Lilly may receive for a new drug.


English High Court, Eli Lilly, GSK, HGS, SPCs

More on this story

GSK avoids $57m damages award over royalties
04-03-2021

LSIPR